SHC Valuation

Sotera Health Co

Add to Watchlist

Advanced Chart

12.300

+0.19(1.569%)1D

Overview
Forecast
Valuation
Earnings

SHC Relative Valuation

SHC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SHC is overvalued; if below, it's undervalued.

Historical Valuation

Sotera Health Co (SHC) is now in the Fair zone, suggesting that its current forward PE ratio of 15.46 is considered Fairly compared with the five-year average of 20.31. The fair price of Sotera Health Co (SHC) is between 11.46 to 19.27 according to relative valuation methord.

Relative Value

Fair Zone

11.46-19.27

Current Price：12.09

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

8.30

P/B

Median3y

9.23

Median5y

9.95

3.15

FCF Yield

Median3y

-1.57

Median5y

-0.29

Competitors Valuation Multiple

The average P/S ratio for SHC's competitors is 3.12, providing a benchmark for relative valuation. Sotera Health Co Corp (SHC) exhibits a P/S ratio of 2.91, which is -6.70% above the industry average. Given its robust revenue growth of 2.56%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap